Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000799698-17-000023
Filing Date
2017-08-03
Accepted
2017-08-02 20:50:43
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT FOR QUARTER ENDING JUNE 30, 2017 ON FORM 10-Q form10q-2q17.htm 10-Q 466579
2 exh31-1.htm EX-31.1 9160
3 exh31-2.htm EX-31.2 9537
4 exh32-1.htm EX-32.1 5217
5 exh32-2.htm EX-32.2 5170
  Complete submission text file 0000799698-17-000023.txt   3400865

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cytr-20170630.xml EX-101.INS 536487
7 XBRL TAXONOMY EXTENSION SCHEMA cytr-20170630.xsd EX-101.SCH 35342
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cytr-20170630_cal.xml EX-101.CAL 32424
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cytr-20170630_def.xml EX-101.DEF 219857
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cytr-20170630_lab.xml EX-101.LAB 463995
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cytr-20170630_pre.xml EX-101.PRE 295094
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

EIN.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15327 | Film No.: 171001875
SIC: 2836 Biological Products, (No Diagnostic Substances)